Trials / Completed
CompletedNCT00277589
LISA-study : Levothyroxin in Nodular Goiter
TSH-adapted Therapy in a Large Randomized, Observer-blind, Placebo-controlled, Prospective Treatment Study of Patients With Nodular Goiter
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 1,024 (actual)
- Sponsor
- Sanofi · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Primary objective: * To evaluate change in total volume of all nodules. Secondary objectives: * To evaluate change in goiter volume after a 12-months treatment, number of nodules and echogenicity of nodules.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Levothyroxin-Na | 1 tablet 30 minutes before breakfast |
| DRUG | Levothyroxine-Na + iodide | 1 tablet 30 minutes before breakfast |
| DRUG | Iodide | 1 tablet 30 minutes before breakfast |
| DRUG | Placebo | 1 tablet 30 minutes before breakfast |
Timeline
- Start date
- 2004-05-01
- Primary completion
- 2008-12-01
- Completion
- 2008-12-01
- First posted
- 2006-01-16
- Last updated
- 2009-12-04
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT00277589. Inclusion in this directory is not an endorsement.